Lobaric acid

For research use only. Not for therapeutic Use.

  • CAT Number: R074532
  • CAS Number: 522-53-2
  • PubChem Substance ID: 73157
  • Molecular Formula: C25H28O8
  • Molecular Weight: 456.491
  • Purity: ≥95%
Inquiry Now

<span style="color:#000000;"><span style="font-size:12px;"><span style="font-family:arial,helvetica,sans-serif;">Lobaric acid (CAS&nbsp;522-53-2)&nbsp;is a depsidone metabolite that has been isolated from <em>Stereocaulon</em>&nbsp;lichen species with antioxidant, antiproliferative, antiviral, and enzyme inhibitory activites.&nbsp;It scavenges superoxide radicals in a cell-free assay (IC<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span>&nbsp;= 97.9 &mu;mol) and inhibits proliferation in a panel of leukemia, colorectal, gastric, breast, ovarian, prostate, pancreatic, and lung cancer cell lines (EC<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span>s = 15.2-63.9 &mu;g/ml).&nbsp;Lobaric acid inhibits protein tyrosine phosphatase 1B (PTP1B; IC<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span>&nbsp;= 0.87 &mu;M for the human recombinant enzyme) and production of 12(S)-HETE by 12(S)-lipoxygenase (IC<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span>&nbsp;= 28.5 &mu;M).&nbsp;<em>In vivo</em>, lobaric acid (250 &mu;M) decreases lesion number, but not lesion diameter, in tobacco leaves infected with tobacco mosaic virus (TMV).</span></span></span>


Catalog Number R074532
CAS Number 522-53-2
Molecular Formula C25H28O8
Purity ≥95%
IUPAC Name 3-hydroxy-9-methoxy-6-oxo-7-pentanoyl-1-pentylbenzo[b][1,4]benzodioxepine-2-carboxylic acid
InChI InChI=1S/C25H28O8/c1-4-6-8-9-15-21(24(28)29)18(27)13-20-23(15)32-19-12-14(31-3)11-16(17(26)10-7-5-2)22(19)25(30)33-20/h11-13,27H,4-10H2,1-3H3,(H,28,29)
InChIKey JHEWMLHQNRHTQX-UHFFFAOYSA-N
SMILES CCCCCC1=C2C(=CC(=C1C(=O)O)O)OC(=O)C3=C(O2)C=C(C=C3C(=O)CCCC)OC
Reference

<span style="color:#000000;"><span style="font-size:12px;"><span style="font-family:arial,helvetica,sans-serif;">1.Gonz&aacute;lez, Antonio G., et al. &quot;Chemical constituents of the lichen Stereocaulon azoreum.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Zeitschrift f&uuml;r Naturforschung C</i>&nbsp;47.7-8 (1992): 503-507.<br />
2.Thadhani, Vinitha M., et al. &quot;Antioxidant activity of some lichen metabolites.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Natural product research</i>&nbsp;25.19 (2011): 1827-1837.<br />
3.Haraldsd&oacute;ttir, Sigurd&iacute;s, et al. &quot;Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Planta medica</i>&nbsp;70.11 (2004): 1098-1100.<br />
4.Ram&iacute;rez, Ingrid, et al. &quot;Lichen depsides and depsidones reduce symptoms of diseases caused by tobacco mosaic virus (TMV) in tobacco leaves.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Natural product communications</i>&nbsp;7.5 (2012): 1934578X1200700514.<br />
5.Seo, Changon, et al. &quot;Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the Antarctic lichen Stereocaulon alpinum.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Bioorganic &amp; medicinal chemistry letters</i>&nbsp;19.10 (2009): 2801-2803.<br />
6.Bucar, F., et al. &quot;Anti-proliferative lichen compounds with inhibitory activity on 12 (S)-HETE production in human platelets.&quot;&nbsp;<i style="font-family: Arial, sans-serif; font-size: 13px;">Phytomedicine</i>&nbsp;11.7-8 (2004): 602-606.</span></span></span>

Request a Quote